---
title: "Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates | CLRB Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286406208.md"
description: "Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates | CLRB Stock News"
datetime: "2026-05-14T03:15:29.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286406208.md)
  - [en](https://longbridge.com/en/news/286406208.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286406208.md)
---

# Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates | CLRB Stock News

Cellectar Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Updates | CLRB Stock News

### Related Stocks

- [CLRB.US](https://longbridge.com/en/quote/CLRB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)

## Related News & Research

- [Full Transcript: Cellectar Biosciences Q1 2026 Earnings Call](https://longbridge.com/en/news/286422585.md)
- [Cellectar Biosciences Raises ~$35 Million in Registered Direct and Private Placement](https://longbridge.com/en/news/285704942.md)
- [Analyst Reiterates Buy on Corbus, Maintains $38 Price Target on CRB-701 Oncology Potential](https://longbridge.com/en/news/286284525.md)
- [Dyadic International Q1 net loss narrows](https://longbridge.com/en/news/286311192.md)
- [Alkermes reports encouraging data from Phase III study of Lumryz](https://longbridge.com/en/news/286349759.md)